Description:
Artenate Suspension is an oral antimalarial medication containing artesunate, designed for the treatment of uncomplicated malaria, particularly in pediatric patients. It is effective against Plasmodium falciparum, including chloroquine-resistant strains. ​

Prescription:
Yes; prescription required.​

Therapeutic Category:
Antimalarial (Artemisinin derivative).​

Composition

Active Ingredient:

• Artesunate.​
  

Vitamins:
None.​

Minerals:
None.​

Product Details

Variant:
Oral suspension, commonly available in 60 ml bottles.​

Consume Type:
Oral; to be administered by mouth.​

Directions/Usage:

• Dosage should be determined by a healthcare provider, based on the patient’s weight and clinical condition.
• For pediatric patients, dosing guidelines suggest 4 mg/kg body weight per day, administered once daily for three consecutive days.
• It’s crucial to complete the full course to prevent relapse.​
  

Common Side Effects:

• Fever.
• Skin rash.
• Neurotoxicity (at high doses).
• Cardiotoxicity (rare).
• Allergic reactions.​
  

Packaging & Storage

Package Type:
Typically supplied in 60 ml bottles.​

Storage Advice:

• Store in a cool, dry place away from direct sunlight.
• Keep out of reach of children.​
  

Safety Information

Safety Advice:

• Not recommended for individuals with known hypersensitivity to artesunate or other artemisinin derivatives.
• Use with caution in patients with liver or kidney impairment.
• Consult a healthcare provider before use during pregnancy or breastfeeding.​
  

Additional Information

Product Substitutes:

• Co-Artesiane Suspension (artemether and lumefantrine combination).
• Other artesunate-based oral suspensions available in the market.​
  

Manufacturer/Marketer:
Entrance Pharmaceuticals

Country of Origin:
Ghana